The just lately granted patent entitled “Techniques and Strategies Utilizing Weighted Ensemble Supervised Studying for Automated Detection of Ophthalmic Ailments from Photos” positions RETINA-AI Well being, Inc. to proceed to steer the event of revolutionary services and products in synthetic intelligence in well being care. .
The founder and CEO of the corporate, Dr. Stephen G. Odaibosays, “Our Synthetic Intelligence options will play a key function in enhancing the standard and decreasing the price of healthcare supply. These cutting-edge revolutionary applied sciences will match excellently in value-based main care settings.” .
ABOUT RETINA-AI Well being, Inc:
RETINA-AI Well being, Inc. is a privately owned Delaware C-Corp based in 2017 and primarily based in Houston, Texas. The corporate is targeted on creating synthetic intelligence to remodel healthcare and enhance outcomes for prevalent power illnesses. Develops and deploys retina-based AI for large-scale systemic power illness detection. RETINA-AI Well being, Inc. has a powerful unwavering dedication to adhering to the very best requirements of high quality and ethics, whereas constantly main the world in AI innovation for healthcare.
Electronic mail: [email protected]
Web site: retinahealth.ai
SOURCE RETINA-AI Well being, Inc.